---
$id: https://graph.org.ai/products/commodity/51112014
$type: Product
source: UNSPSC
code: "51112014"
title: "Erlotinib hydrochloride"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Erlotinib hydrochloride

**UNSPSC Code**: 51112014
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an epidermal growth factor receptor tyrosine kinase inhibitor with the molecular formula C22H23N3O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DA87705X9K, chemically known as 4-quinazolinamine, n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride but more generally known as erlotinib hydrochloride, which bears US NIH Compound Identifier 176871. European Medicines Agency schedules Erlotinib hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21050. As of Q4 2014, ERLOTINIB HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Erlotinib hydrochloride bears US NLM identifiers UMLS ID C0910101 and NCI Concept Code C2693. Most nations, for tariff and trade purposes, schedule erlotinib hydrochloride under HS 29335995 and SITC 51576. SMILES: COCCOC1CC2C(CC1OCCOC)NCNC2NC3CCCC(C3)C#C.CL.

